Skip to main content
Caplight Logo









CardioRenal Systems

CardioRenal Systems

Private
Milford, MassachusettsHealthcare & Life Scienceshttps://cardiorenalsystems.com/

Last Round

Corporate Funding

Jul 7, 2026

Total Funding Raised

$15.5M

Company Overview

CardioRenal Systems is a medical device company that develops and markets the RenalPro™ system, a clinically validated solution designed to prevent acute kidney injury (AKI) in hospitalized patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

acute kidney injuryAKIfluid managementclosed-loop systemhemodynamic stabilitymedical deviceurine output monitoringcardiac surgerycritical careMedTechpatient monitoringIV fluid managementhospital equipmentclinical automationrenal care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CardioRenal Systems Comparables

Compare CardioRenal Systems with similar companies based on industry and business-model similarity.

CardioRenal Systems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Accuryn Medical
88%
Renalert LLC
83%
Serenno Medical
81%

CardioRenal Systems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJul 7, 2026
Series AMar 16, 2017
DebtJul 3, 2012

Key People

Founding team and executive leadership

Ilya Budik

CEO

Executive Team

Mark Tauscher

President & CEO

Executive Team

Tzvi Stern

Chief Financial Officer

Executive Team

CardioRenal Systems Investors

Notable investors and investment history

CardioRenal Systems investors
InvestorRounds
Exigent CapitalSeries A
Genesis Capital AdvisorsSeries A
Angel Physicians FundCorporate Funding
Genesis Capital Advisors, LLCDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 16, 2017

    $15M round led by Exigent Capital

CardioRenal Systems Filings

Explore SEC and related filing metadata, where available.

CardioRenal Systems filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CardioRenal Systems's valuation, stock price, and market status.

Is CardioRenal Systems a public or private company?

CardioRenal Systems is a private company.

What is the current stock price of CardioRenal Systems?

CardioRenal Systems is a private company with no public stock price. No recent secondary market data is available.

How much is CardioRenal Systems worth (valuation)?

Valuation information for CardioRenal Systems is not publicly available.

Can I buy CardioRenal Systems stock?

CardioRenal Systems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CardioRenal Systems's last funding round?

CardioRenal Systems's most recent funding round was Corporate Funding on July 7, 2026.

Who are the main investors in CardioRenal Systems?

Key investors in CardioRenal Systems include Exigent Capital, Genesis Capital Advisors, LLC.

Will CardioRenal Systems IPO soon?

No public IPO plans have been announced for CardioRenal Systems.

How can I track CardioRenal Systems secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CardioRenal Systems's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMilford, Massachusetts
Employee Range17
Year FoundedN/A
Last FundingJul 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?